NRC NRC HEALTH revenue, earnings and financials

For the quarter ended June 30, 2026, NRC HEALTH reported revenue of $35.4M (up 4.0% from a year earlier), net income of −$3.28M and diluted EPS of −$0.15; over the last four quarters revenue was $140M and net income $5.86M; for the fiscal year ended December 2025 revenue was $137M, down 4.0% on the year before.

NRC annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $137M, gross profit n/a, operating income $22.6M, net income $11.6M (margin 8.4%), EPS $50.00
• Fiscal year ended Dec 2024: revenue $143M, gross profit n/a, operating income $35.2M, net income $24.8M (margin 17.3%), EPS $1.04
• Fiscal year ended Dec 2023: revenue $149M, gross profit n/a, operating income $40.0M, net income $31.0M (margin 20.8%), EPS $1.25
• Fiscal year ended Dec 2022: revenue $152M, gross profit n/a, operating income $46.5M, net income $31.8M (margin 21.0%), EPS $1.27
• Fiscal year ended Dec 2021: revenue $148M, gross profit n/a, operating income $50.3M, net income $37.5M (margin 25.3%), EPS $1.46

NRC quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $35.4M (up 4.0% year over year), net income −$3.28M, EPS −$0.15
• Quarter ended Mar 31, 2026: revenue $34.8M (up 3.7% year over year), net income $3.22M, EPS $0.14
• Quarter ended Dec 31, 2025 (from the annual report): revenue $35.2M (down 4.6% year over year), net income $1.80M, EPS $49.58
• Quarter ended Sep 30, 2025: revenue $34.6M (down 3.4% year over year), net income $4.12M, EPS $0.18
• Quarter ended Jun 30, 2025: revenue $34.0M (down 2.8% year over year), net income −$106K, EPS −$0.01
• Quarter ended Mar 31, 2025: revenue $33.6M (down 5.0% year over year), net income $5.79M, EPS $0.25
• Quarter ended Dec 31, 2024 (from the annual report): revenue $36.9M (down 2.9% year over year), net income $6.56M, EPS $0.27
• Quarter ended Sep 30, 2024: revenue $35.8M (down 5.6% year over year), net income $5.69M, EPS $0.24
• Quarter ended Jun 30, 2024: revenue $35.0M (down 3.2% year over year), net income $6.18M, EPS $0.26
• Quarter ended Mar 31, 2024: revenue $35.3M (down 3.2% year over year), net income $6.36M, EPS $0.27
• Quarter ended Dec 31, 2023 (from the annual report): revenue $38.0M (down 0.4% year over year), net income $8.86M, EPS $0.36
• Quarter ended Sep 30, 2023: revenue $37.9M (up 0.7% year over year), net income $7.88M, EPS $0.32
• Quarter ended Jun 30, 2023: revenue $36.2M (down 3.0% year over year), net income $7.27M, EPS $0.29
• Quarter ended Mar 31, 2023: revenue $36.5M (down 5.1% year over year), net income $6.96M, EPS $0.28
• Quarter ended Dec 31, 2022 (from the annual report): revenue $38.1M (down 0.4% year over year), net income $6.64M, EPS $0.27
• Quarter ended Sep 30, 2022: revenue $37.7M (down 0.2% year over year), net income $8.30M, EPS $0.33
• Quarter ended Jun 30, 2022: revenue $37.3M (up 2.4% year over year), net income $8.32M, EPS $0.33
• Quarter ended Mar 31, 2022: revenue $38.4M (up 8.4% year over year), net income $8.54M, EPS $0.34
• Quarter ended Dec 31, 2021 (from the annual report): revenue $38.3M, net income $9.63M, EPS $0.37
• Quarter ended Sep 30, 2021: revenue $37.8M, net income $9.66M, EPS $0.38

NRC cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $26.5M, share buybacks $20.2M, dividends $0.52 per share
• Fiscal year ended Dec 2024: operating cash flow $34.6M, share buybacks $30.9M, dividends $0.48 per share
• Fiscal year ended Dec 2023: operating cash flow $38.1M, share buybacks $19.1M, dividends $1.48 per share
• Fiscal year ended Dec 2022: operating cash flow $36.3M, share buybacks $27.6M, dividends $0.84 per share
• Fiscal year ended Dec 2021: operating cash flow $46.3M, share buybacks $4.14M, dividends $0.48 per share

NRC balance sheet

• Jun 30, 2026: cash $3.33M, total assets $136M, total liabilities $130M, shareholders' equity $6.55M, long-term debt $86.0M
• Mar 31, 2026: cash $2.55M, total assets $135M, total liabilities $121M, shareholders' equity $13.5M, long-term debt $74.0M
• Dec 31, 2025: cash $4.14M, total assets $135M, total liabilities $121M, shareholders' equity $14.0M, long-term debt $75.0M
• Sep 30, 2025: cash $2.22M, total assets $136M, total liabilities $121M, shareholders' equity $14.3M, long-term debt $76.0M
• Jun 30, 2025: cash $5.27M, total assets $141M, total liabilities $120M, shareholders' equity $21.3M, long-term debt $77.0M
• Mar 31, 2025: cash $2.50M, total assets $135M, total liabilities $106M, shareholders' equity $29.7M, long-term debt $58.7M
• Dec 31, 2024: cash $4.23M, total assets $133M, total liabilities $101M, shareholders' equity $31.3M, long-term debt $57.9M
• Sep 30, 2024: cash $3.46M, total assets $132M, total liabilities $97.2M, shareholders' equity $34.6M, long-term debt $44.9M

What is NRC's revenue?

NRC HEALTH reported $140M of revenue over its last four quarters, through June 30, 2026.

Is NRC profitable?

Yes. NRC HEALTH earned $5.86M over the last four quarters.

What is NRC's EPS?

Diluted earnings per share over the last four quarters were $49.75; −$0.15 in the latest quarter.

Does NRC pay a dividend?

NRC HEALTH paid $0.52 per share in dividends in the fiscal year ended December 2025.

NRC ownership and insider trades · All stocks